| Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis A Cipriani, TA Furukawa, G Salanti, JR Geddes, JPT Higgins, R Churchill, ... The lancet 373 (9665), 746-758, 2009 | 2637* | 2009 |
| Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ... The Lancet 382 (9896), 951-962, 2013 | 2576 | 2013 |
| Imputing missing standard deviations in meta-analyses can provide accurate results TA Furukawa, C Barbui, A Cipriani, P Brambilla, N Watanabe Journal of clinical epidemiology 59 (1), 7-10, 2006 | 1169 | 2006 |
| Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis G Targher, CD Byrne, A Lonardo, G Zoppini, C Barbui Journal of hepatology 65 (3), 589-600, 2016 | 959 | 2016 |
| Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta … S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen, AJ Hayes, ... The Lancet Psychiatry 5 (9), 727-738, 2018 | 686 | 2018 |
| Major depression in multiple sclerosis: a population-based perspective SB Patten, CA Beck, JVA Williams, C Barbui, LM Metz Neurology 61 (11), 1524-1527, 2003 | 676 | 2003 |
| Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis IA Cristea, C Gentili, CD Cotet, D Palomba, C Barbui, P Cuijpers Jama psychiatry 74 (4), 319-328, 2017 | 610 | 2017 |
| Mental health and psychosocial support in humanitarian settings: linking practice and research WA Tol, C Barbui, A Galappatti, D Silove, TS Betancourt, R Souza, ... The Lancet 378 (9802), 1581-1591, 2011 | 607 | 2011 |
| How often do patients with psychosis fail to adhere to treatment programmes? A systematic review M Nose, C Barbui, M Tansella Psychological medicine 33 (7), 1149-1160, 2003 | 445 | 2003 |
| Escitalopram versus other antidepressive agents for depression A Cipriani, C Santilli, TA Furukawa, A Signoretti, A Nakagawa, H McGuire, ... Cochrane Database of Systematic Reviews, 2009 | 375 | 2009 |
| Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis M Hoskins, J Pearce, A Bethell, L Dankova, C Barbui, WA Tol, ... The British Journal of Psychiatry 206 (2), 93-100, 2015 | 360 | 2015 |
| Evidence-based guidelines for mental, neurological, and substance use disorders in low-and middle-income countries: summary of WHO recommendations T Dua, C Barbui, N Clark, A Fleischmann, V Poznyak, M van Ommeren, ... PLoS medicine 8 (11), e1001122, 2011 | 341 | 2011 |
| Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies C Barbui, E Esposito, A Cipriani Cmaj 180 (3), 291-297, 2009 | 327 | 2009 |
| Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies G Turrini, M Purgato, F Ballette, M Nosč, G Ostuzzi, C Barbui International journal of mental health systems 11 (1), 1-14, 2017 | 290 | 2017 |
| Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis C Barbui, A Cipriani, V Patel, JL Ayuso-Mateos, M van Ommeren The British Journal of Psychiatry 198 (1), 11-16, 2011 | 286 | 2011 |
| Clinical interventions for treatment non-adherence in psychosis: meta-analysis M Nosé, C Barbui, R Gray, M Tansella The British Journal of Psychiatry 183 (3), 197-206, 2003 | 267 | 2003 |
| Sertraline versus other antidepressive agents for depression A Cipriani, T La Ferla, TA Furukawa, A Signoretti, A Nakagawa, ... Cochrane Database of Systematic Reviews, 2010 | 262 | 2010 |
| Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials Y Hayasaka, M Purgato, LR Magni, Y Ogawa, N Takeshima, A Cipriani, ... Journal of affective disorders 180, 179-184, 2015 | 260 | 2015 |
| Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials C Barbui, M Hotopf The British Journal of Psychiatry 178 (2), 129-144, 2001 | 256 | 2001 |
| Mirtazapine versus other antidepressive agents for depression N Watanabe, IM Omori, A Nakagawa, A Cipriani, C Barbui, R Churchill, ... Cochrane Database of Systematic Reviews, 2011 | 245 | 2011 |
